2022-01-17
Shanghai, Jan. 17th, 2022 - Tyligand Bioscience, a clinical-stage biotechnology company developing innovative small-molecule therapeutics against drug resistant cancers, today announced that its investigational new drug (IND) appl ...
2021-10-20
Tyligand Bioscience, a clinical-stage biotechnology company developing innovative small-molecule therapeutics against drug resistant cancers, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investig ...
Cancer is fast becoming the leading cause of death in developed nations and is also having a devastating effect on the families of patients and healthcare systems of the developing economies. Despite recent breakthroughs in t ...
The immune system is a double-edged sword. The new generation of immunomodulators should have a clear mechanism of action, be capable of only blocking the attack of the immune system on normal tissues, but also allowing it to ...
We are seeking for qualified talents with passion and integrity to join and grow with our dynamic teams. You are welcome to apply for opening positions listed below by email. Please indicate the Position Number in the email subject of your application.